Insider Transactions in Q2 2024 at Broadridge Financial Solutions, Inc. (BR)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2024
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
144
+1.26%
|
-
|
|
Jun 13
2024
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
163
+0.65%
|
-
|
|
Jun 13
2024
|
Eileen K Murray Director |
BUY
Grant, award, or other acquisition
|
Direct |
144
+6.21%
|
-
|
|
Jun 13
2024
|
Annette L. Nazareth Director |
BUY
Grant, award, or other acquisition
|
Direct |
144
+3.8%
|
-
|
|
Jun 13
2024
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
132
+1.96%
|
-
|
|
Jun 05
2024
|
Robert N Duelks Director |
SELL
Open market or private sale
|
Direct |
3,473
-13.33%
|
$687,654
$198.06 P/Share
|
|
Jun 05
2024
|
Robert N Duelks Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,469
+19.89%
|
$291,105
$45.09 P/Share
|
|
May 20
2024
|
Thomas P Carey Corporate VP |
SELL
Open market or private sale
|
Direct |
2,500
-21.08%
|
$500,000
$200.4 P/Share
|
|
May 10
2024
|
Richard John Stingi Corporate VP and CHRO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
400
-7.89%
|
$77,600
$194.03 P/Share
|
|
Apr 08
2024
|
Thomas P Carey Corporate VP |
SELL
Payment of exercise price or tax liability
|
Direct |
1,442
-10.84%
|
$291,284
$202.75 P/Share
|
|
Apr 05
2024
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
42
+0.19%
|
-
|
|
Apr 05
2024
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
65
+0.13%
|
-
|
|
Apr 05
2024
|
Eileen K Murray Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.15%
|
-
|
|
Apr 05
2024
|
Annette L. Nazareth Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.17%
|
-
|
|
Apr 05
2024
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.19%
|
-
|
|
Apr 05
2024
|
Leslie A Brun Director |
BUY
Grant, award, or other acquisition
|
Direct |
110
+0.15%
|
-
|
|
Apr 05
2024
|
Pamela L Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.39%
|
-
|
|
Apr 05
2024
|
Robert N Duelks Director |
BUY
Grant, award, or other acquisition
|
Direct |
77
+0.39%
|
-
|
|
Apr 05
2024
|
Melvin L Flowers Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.35%
|
-
|
|
Apr 01
2024
|
Christopher John Perry President |
SELL
Payment of exercise price or tax liability
|
Direct |
3,362
-5.64%
|
$682,486
$203.23 P/Share
|
|
Apr 01
2024
|
Edmund Reese Corporate VP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,896
-27.88%
|
$587,888
$203.23 P/Share
|
|
Apr 01
2024
|
Douglas Richard Deschutter Co-President ICS |
SELL
Payment of exercise price or tax liability
|
Direct |
703
-2.16%
|
$142,709
$203.23 P/Share
|
|
Apr 01
2024
|
Robert F Kalenka Corporate Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
692
-2.51%
|
$140,476
$203.23 P/Share
|
|
Apr 01
2024
|
Richard J Daly Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
438
-0.39%
|
$88,914
$203.23 P/Share
|
|
Apr 01
2024
|
Laura Matlin CVP, Deputy GC and CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
278
-4.29%
|
$56,434
$203.23 P/Share
|
|
Apr 01
2024
|
Richard John Stingi Corporate VP and CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
928
-15.47%
|
$188,384
$203.23 P/Share
|
|
Apr 01
2024
|
Timothy C Gokey CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,227
-6.88%
|
$2,482,081
$203.23 P/Share
|